Interview with Laura Hawks, MD, author of Trends in Unmet Need for Physician and Preventive Services in the United States, 1998-2017, and John Z. Ayanian, MD, MPP, author of Looking Back to Improve Access to Health Care Moving Forward

Interview with Arash Mostaghimi, author of Association Between Sexual Orientation and Lifetime Prevalence of Skin Cancer in the United States, and Howa Yeung, MD MSc, author of Sexual and Gender Minority Populations and Skin Cancer—New Data and Renewed Priorities

Interview with Alexia Mattei, MD, author of Feasibility of First Injection of Autologous Adipose Tissue–Derived Stromal Vascular Fraction in Human Scarred Vocal Folds: A Nonrandomized Controlled Trial

Interview with Nima Sharifi, M.D., author of HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Interview with Keisuke Kawata, PhD, author of Neuro-Ophthalmologic Response to Repetitive Subconcussive Head Impacts: A Randomized Clinical Trial

Interview with James F. Howard, MD, author of Clinical Effects of Self-administered Subcutaneous Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

Interview with Paulina Salminen, MD, PhD, and Suvi Sippola, MD, authors of Quality of Life and Patient Satisfaction at 7-Year Follow-up of Antibiotic Therapy vs Appendectomy for Uncomplicated Acute Appendicitis: A Secondary Analysis of a Randomized Clinical Trial

Interview with Christina Vandenbroucke-Grauls, MD, PhD, author of Evaluation of the Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With Multidrug-Resistant Microorganisms: A Systematic Review and Meta-analysis, and Todd Campbell Lee, MD MPH, author of Deprescribing Proton Pump Inhibitors: Overcoming Resistance

Interview with Caroline A. Nelson, MD, author of Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study

Interview with Sharon Saydah, PhD, MHS, author of Eye Care Among US Adults at High Risk for Vision Loss in the United States in 2002 and 2017

Interview with Schuyler Jones, MD, and Adrian F Hernandez, MD, MHS, authors of Rationale and Design of the Aspirin Dosing—A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial

Interview with Ajita S. Prabhu, MD, and Michael J Rosen, MD, FACS, authors of Robotic Inguinal vs Transabdominal Laparoscopic Inguinal Hernia Repair: The RIVAL Randomized Clinical Trial

Interview with Eric Adjei Boakye, PhD, author of Multilevel Associations Between Patient- and Hospital-Level Factors and In-Hospital Mortality Among Hospitalized Patients With Head and Neck Cancer

Interview with Jason Ying Kuen Chan, MBBS, author of Practical Aspects of Otolaryngologic Clinical Services During the 2019 Novel Coronavirus Epidemic: An Experience in Hong Kong

Interview with Ramin Mojtabai, MD, PhD, author of National Trends in Mental Health Care for US Adolescents

Interview with Robert O. Bonow, MD, Patrick T. O'Gara, MD, Clyde W. Yancy, MD, and Gregg C. Fonarow, MD, authors of Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality and Ajay J. Kirtane, MD

Interview with Brad Spellberg, MD, author of Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review

Interview with Alfred Sommer, MD, author of Humans, Viruses, and the Eye—An Early Report From the COVID-19 Front Line

Interview with Joshua K Tay, author of Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak, and Babak Givi, MD, author of Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic

Interview with Reisa A. Sperling, MD, author of Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals

Interview with Naiyer A. Rizvi, MD, author of Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial

Interview with Christopher P. Childers, MD, PhD, and Melinda Maggard Gibbons, MD, authors of Assessment of the Contribution of the Work Relative Value Unit Scale to Differences in Physician Compensation Across Medical and Surgical Specialities

Interview with Charles Dolladille, MD, author of Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer

Interview with Mara A. Schonberg, MD, MPH, author of Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial, and Quyen Ngo-Metzger, MD, MPH, author of The Life and Death of Mammograms in Patients 75 Years and Older—To Screen or Not to Screen?

Interview with Kristin M Holland, PhD, MPH, author of Trends in the Incidence and Lethality of Suicidal Acts in the United States, 2006 to 2015

Interview with Hsien-Ho Lin, MD, ScD, author of Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset

Interview with Ateev Mehrotra, MD, author of Trends Among Rural and Urban Medicare Beneficiaries in Care Delivery and Outcomes for Acute Stroke and Transient Ischemic Attacks, 2008-2017

Bank of England's statement that Britain could be headed for its biggest economic slump in over 300 years due to the coronavirus lockdown also weighed on the investor sentiment

This was the sixth successive year of net inflows in equity mutual funds

A total of 13 companies, including SBI Cards and Shree Cements, are scheduled to announce their March quarter results today

Jio Platforms has now raised Rs 60,596.37 crore from leading technology investors in less than three weeks.

On Thursday, UK-based Glaxo-SmithKline (GSK) offloaded its stake in HUL via block deals.

The company controlled by Mukesh Ambani, is in discussions with banks for a potential sale of its 4.9 per cent stake in Asian Paints through a series of block trades, reports suggest.

Novelis informed that its net income attributable to its common shareholder came in at $63 million for the quarter under review, down 39 per cent year-on-year (YoY

Till 12:44 pm, a combined 34.4 million equity shares, representing 32.2 per cent of total equity of Laurus Labs, changed hands on the BSE and NSE.

BSE Sensex ended at 31,642.70, up 199 points or 0.63 per cent, with HUL (up nearly 5 per cent) being the top gainer and NTPC (down nearly 4 per cent) the biggest loser

The previous events fueled huge rallies in bitcoin's market value, but there is a wildcard this time in the form of the coronavirus pandemic, some analysts said.